Articles from Abraham, Fruchter & Twersky, LLP
Abraham, Fruchter & Twersky LLP Notifies Shareholders of a Class Action Lawsuit on Behalf of Investors who Acquired Shares of Akero Therapeutics, Inc. (NYSE: AKRO)
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (www.aftlaw.com), a nationally recognized law firm that focuses on protecting investors’ rights, informs shareholders of a class action lawsuit on behalf of investors who purchased Akero Therapeutics, Inc. (“Akero”) (NYSEAKRO) common stock captioned Klobus v. Akero Therapeutics, Inc., No. 3:24-cv-02534 (N.D. Cal.).
By Abraham, Fruchter & Twersky, LLP · Via GlobeNewswire · May 16, 2024
MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF)
NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (https://aftlaw.com/), a nationally recognized law firm that focuses on protecting investors’ rights, is investigating whether Morphic Holding, Inc. (NASDAQMORF), a biopharmaceutical company, violated U.S. federal securities laws by making false or misleading statements or failing to timely disclose material information to investors.
By Abraham, Fruchter & Twersky, LLP · Via GlobeNewswire · March 20, 2024
AKRO Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Akero Therapeutics (NASDAQ:AKRO)
NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (https://aftlaw.com/), a nationally recognized law firm that focuses on protecting investors’ rights, is investigating whether Akero Therapeutics (NASDAQAKRO), a clinical-stage biotechnology company, violated U.S. federal securities laws by making false or misleading statements or failing to timely disclose material information to investors.
By Abraham, Fruchter & Twersky, LLP · Via GlobeNewswire · March 20, 2024
Abraham, Fruchter & Twersky LLP Notifies Shareholders of a Class Action Lawsuit on Behalf of Investors who Acquired Shares of AT&T Inc. (NYSE: T)
NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (www.aftlaw.com), a nationally recognized law firm that focuses on protecting investors’ rights, announces its filing of a class action lawsuit on behalf of investors who purchased AT&T common stock captioned General Retirement System of the City of Detroit v. AT&T Inc., No. 23-cv-07351 (S.D.N.Y.).
By Abraham, Fruchter & Twersky, LLP · Via GlobeNewswire · August 29, 2023
Abraham, Fruchter & Twersky LLP Notifies Shareholders of a Class Action Lawsuit on Behalf of Investors who Acquired Shares of Verizon Communications Inc. (NYSE: VZ)
NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Abraham, Fruchter & Twersky, LLP (www.aftlaw.com), a nationally recognized law firm that focuses on protecting investors’ rights, announces its filing of a class action lawsuit on behalf of investors who purchased Verizon common stock captioned General Retirement System of the City of Detroit v. Verizon Communications, Inc., No. 23-cv-05218 (D.N.J.).
By Abraham, Fruchter & Twersky, LLP · Via GlobeNewswire · August 29, 2023